中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial

文献类型:期刊论文

作者Hung, Chung-Chieh2,3; Lee, Chien-Hung4,5,6; Ko, Albert Min-Shan7; Lane, Hsien-Yuan1,2,3; Lee, Chi-Pin8; Ko, Ying-Chin8
刊名EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES
出版日期2020
卷号29页码:10
关键词Clinical drug studies common mental disorders epidemiology psychoactive substance use disorder randomised controlled trials
ISSN号2045-7960
DOI10.1017/S2045796020000384
通讯作者Ko, Ying-Chin(ycko0406@gmail.com)
英文摘要Aims More than one-half of betel-quid (BQ) chewers have betel-quid use disorder (BUD). However, no medication has been approved. We performed a randomised clinical trial to test the efficacy of taking escitalopram and moclobemide antidepressants on betel-quid chewing cessation (BQ-CC) treatment. Methods We enrolled 111 eligible male BUD patients. They were double-blinded, placebo-controlled and randomised into three treatment groups: escitalopram 10 mg/tab daily, moclobemide 150 mg/tab daily and placebo. Patients were followed-up every 2 weeks and the length of the trial was 8 weeks. The primary outcome was BQ-CC, defined as BUD patients who continuously stopped BQ use for > 6 weeks. The secondary outcomes were the frequency and amount of BQ intake, and two psychological rating scales. Several clinical adverse effects were measured during the 8-week treatment. Results Intention-to-treat analysis shows that after 8 weeks, two (5.4%), 13 (34.2%) and 12 (33.3%) of BUD patients continuously quit BQ chewing for > 6 weeks among placebo, escitalopram, moclobemide groups, respectively. The adjusted proportion ratio of BQ-CC was 6.3 (95% CI 1.5-26.1) and 6.8 (95% CI 1.6-28.0) for BUD patients who used escitalopram and moclobemide, respectively, as compared with those who used placebo. BUD patients with escitalopram and moclobemide treatments both exhibited a significantly lower frequency and amount of BQ intake at the 8th week than those with placebo. Conclusions Prescribing a fixed dose of moclobemide and escitalopram to BUD patients over 8 weeks demonstrated treatment benefits to BQ-CC. Given a relatively small sample, this study provides preliminary evidence and requires replication in larger trials.
WOS关键词OBSESSIVE-COMPULSIVE SCALE ; PROTEIN MODIFICATION ; CHINESE VERSION ; ARECA NUT ; DEPENDENCE ; SUBSTRATE ; ESCITALOPRAM ; INVENTORY ; SEVERITY ; MEMORY
资助项目Taiwan Ministry of Health and Welfare Clinical Trial Center[MOHW109-TDU-B212-114004] ; China Medical University Hospital[DMR-106-098] ; China Medical University Hospital[DMR-108-094]
WOS研究方向Psychiatry
语种英语
WOS记录号WOS:000530304700001
出版者CAMBRIDGE UNIV PRESS
资助机构Taiwan Ministry of Health and Welfare Clinical Trial Center ; China Medical University Hospital
源URL[http://119.78.100.205/handle/311034/17417]  
专题古脊椎动物与古人类研究所_图书馆1
通讯作者Ko, Ying-Chin
作者单位1.Asia Univ, Coll Med & Hlth Sci, Dept Psychol, Taichung, Taiwan
2.China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan
3.China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan
4.Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan
5.Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan
6.Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan
7.Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China
8.China Med Univ, China Med Univ Hosp, Environm Omics Dis Res Ctr, Taichung, Taiwan
推荐引用方式
GB/T 7714
Hung, Chung-Chieh,Lee, Chien-Hung,Ko, Albert Min-Shan,et al. Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial[J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES,2020,29:10.
APA Hung, Chung-Chieh,Lee, Chien-Hung,Ko, Albert Min-Shan,Lane, Hsien-Yuan,Lee, Chi-Pin,&Ko, Ying-Chin.(2020).Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial.EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES,29,10.
MLA Hung, Chung-Chieh,et al."Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial".EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES 29(2020):10.

入库方式: OAI收割

来源:古脊椎动物与古人类研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。